InGeneron's Transpose® Ultra System is for investigational use only in the US. By Clicking 'Continue' I confirm acknowledgment


Board of Directors

Page Header Image

Eckhard Alt, MD, PhD
Executive Chairman of InGeneron, Inc.

Eckhard U. Alt is professor of medicine and biomedical engineering at Tulane University in New Orleans and was professor of medicine at University of Texas MD Anderson Cancer Center in Houston and at Technical University of Munich. He received his medical degree as valedictorian from Heidelberg Medical School. After two years in cardiac surgery at the Ludwig-Maximilians-University Munich, he completed his education at Technical University of Munich in internal medicine/cardiology.

Eckhard is a frequent reviewer and serves on the editorial boards of respected journals. From 2001 to 2007, he was president of the Cardiac Electrophysiology Society. He has organized major national and international congresses; authored more than 500 publications in peer-reviewed journals, books, or book chapters; and has acquired more than 600 worldwide patents, primarily in the fields of stem cells, electrophysiology, and interventional cardiology. The magazine Focus rated him among the “Best 12 Cardiologists in Germany.” Eckhard received the Hahn Research Award from the European Society of Thoracic Surgeons as well as the Ethica Award as Best Experimental Researcher from Erasmus University in Rotterdam. In 2009, he was named Entrepreneur of the Year in Munich and Innovator of the Year in Houston. In addition to being Executive Chairman of InGeneron, Inc., he is also chairman of the board of ISAR Klinikum in Munich, Germany.


Bobby I. Griffin, PhD

Bobby I. Griffin retired from a 25-year career with Medtronic, Inc., where he held various executive-level positions, including president of Medtronic’s CRM Business from 1991 to 1998. He manages his own fund of companies and serves on the advisory boards of Affinity Capital Management Fund III and IV and Sapient Capital Management Fund, in which he also invests. In addition, Bobby has served on the board of directors of several public companies, including MTS Systems Corporation and Urologix, Inc., and is currently a director of several private companies.


Jerry C. Griffin, MD

Jerry C. Griffin is president of Griffin & Schwartz, Scientific Services Inc., a management consulting firm in the health care products field. He has assisted several development stage companies in areas ranging from venture and public financing to FDA and clinical trial strategy. He is currently a member of the boards of directors of a number of private companies. During his academic tenure, Jerry held leadership positions in several national and international cardiology organizations and is the author or coauthor of five books, four patents, and over 170 medical and scientific articles.


Klaus L. Keller

Klaus L. Keller is founding chairman, CEO, and majority shareholder of Sueba USA Corporation in Houston, Texas. He is active in the areas of acquisition, development, and management of U.S. real estate and real estate investment funds. Klaus is also a private investor and syndicator.


Kelby K. Krabbenhoft

Kelby K. Krabbenhoft is president and chief executive officer of Sanford Health, one of the largest integrated U.S. health systems with 45 hospitals and nearly 300 clinics in nine states and three countries. He has served as president and chief executive officer since 1996. During his tenure, Kelby has led dynamic growth and development of the health system and created the vision for Denny Sanford’s nearly $1 billion gifts. Kelby’s previous positions include president and chief executive officer, Freeman Health System, Joplin, Mo.; executive vice president, Sisters of Mary of the Presentation Health Corporation, Fargo, N.D.; president, St. Margaret’s Hospital, Spring Valley, Ill.; and president, Guttenberg Hospital, Guttenberg, Iowa. Kelby holds an MBA from Minnesota State University, Mankato.